- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Growth Stocks
U.S. Pharmaceuticals & Biotech High Growth Stocks
Results
6
High Growth Stocks
6 companies
Zevra Therapeutics
Market Cap: US$663.9m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.32
7D
-2.1%
1Y
20.0%
Kiniksa Pharmaceuticals International
Market Cap: US$6.1b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$76.75
7D
0.9%
1Y
129.9%
Arcutis Biotherapeutics
Market Cap: US$3.2b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.19
7D
3.6%
1Y
55.1%
Eton Pharmaceuticals
Market Cap: US$1.7b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$58.86
7D
32.0%
1Y
245.4%
BeOne Medicines
Market Cap: US$40.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$347.48
7D
-0.2%
1Y
8.1%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.89
7D
0.2%
1Y
20.0%